Chapter 285

The document announced a forty percent reduction in medical insurance reimbursement rates for 'Class III Biological Neural Regeneration Medical Products,' while simultaneously opening a fast-track approval channel for 'neural signal transmission intervention devices.'

John saw the notification at ...

Login and Continue Reading